Casa Recovery
-
Services:
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Male
- Female
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients with co-occurring mental and substance use disorders
- Clients who have experienced trauma
- Seniors or older adults
- Clients who have experienced sexual abuse
- Clients with co-occurring pain and substance use disorders
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- Vaping permitted in designated area
- Smoking permitted in designated area
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Prescribes naltrexone
- Cash or self-payment
- Private health insurance
- Young Adults
- Adults
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Outcome follow-up after discharge
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Outpatient
- Regular outpatient treatment
- Outpatient day treatment or partial hospitalization
- Intensive outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Transportation assistance
- Mental health services
- Integrated primary care services
- Domestic violence services, including family or partner
- Case management service
- Suicide prevention services
- Social skills development
- Housing services
- Self-help groups
- Assistance with obtaining social services
- The Joint Commission
- State Substance use treatment agency
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Disulfiram
- Buprenorphine with naloxone
- Naltrexone (extended-release, injectable)
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Clonidine
- Acamprosate (Campral®)
- Medications for HIV treatment
- Medication for mental disorders
- Private for-profit organization
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- Screening for substance use
- Comprehensive substance use assessment
- Screening for mental disorders
- Comprehensive mental health assessment
- Complete medical history/physical exam
- Screening for tobacco use
- Substance use disorder counseling
- Relapse prevention
- Anger management
- Contingency management/motivational incentives
- Cognitive behavioral therapy
- Matrix Model
- Motivational interviewing
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Brief intervention
- 12-step facilitation
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Drug and alcohol oral fluid testing
- Group counseling
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Individual counseling
- Family counseling
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Marital/couples counseling
- Smoking/vaping/tobacco cessation counseling
- Treatment for other addiction disorder
Type of Care
Type of Alcohol Use Disorder Treatment
Gender Accepted
Special Programs/Groups Offered
External Opioid Medications Source
Facility Vaping Policy
Facility Smoking Policy
Type of Opioid Treatment
Payment/Insurance/Funding Accepted
Age Groups Accepted
Transitional Services
Opioid Medications used in Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Ancillary Services
Recovery Support Services
License/Certification/Accreditation
Pharmacotherapies
Facility Operation (e.g., Private, Public)
External Source of Medications Used for Alcohol Use Disorder Treatment
Assessment/Pre-treatment
Treatment Approaches
Testing
Education and Counseling Services
Other Services